immune dysregulation and clonal hematopoiesis in mds
Published 1 year ago • 102 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
1:51
factors driving the transformation of chip to mds
-
1:38
the role and targeting of immune dysregulation in mds
-
1:32
clonal hematopoiesis & mds
-
1:53
the role of chronic inflammation in clonal hematopoiesis and the development of mds
-
2:03
molecular pathogenesis and immune dysregulation in mds
-
1:32
the role of the innate immune system in mds pathogenesis
-
1:53
immune dysregulation in mds and bone marrow failure disorders
-
17:05
your medical specialty based on personality | myers-briggs breakdown
-
1:24:51
mds 2023: ps 2 - from clonal hematopoiesis to overt mds
-
6:45
clonal hematopoiesis of indeterminate potential as a novel risk factor for stroke
-
0:38
pain management for patients with scd and thalassemia in lebanon
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
1:59
topics of interest in mds: the role of maintenance therapy, immune checkpoints & ven-aza in hr-mds
-
3:50
the impact of clonal hematopoiesis on outcomes of all
-
9:41
the i4mds consortium and immune monitoring in mds
-
2:47
incidence & clinical significance of clonal hematopoiesis in healthy vs aml patients
-
3:25
identifying & monitoring patients with high-risk clonal hematopoiesis
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
0:53
challenges with bringing novel immune therapies to mds
-
2:56
innate immunity in mds pathogenesis
-
4:27
the role of immune checkpoint inhibitors in mds